DrugCite
Search

LOXEN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Loxen Adverse Events Reported to the FDA Over Time

How are Loxen adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Loxen, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Loxen is flagged as the suspect drug causing the adverse event.

Most Common Loxen Adverse Events Reported to the FDA

What are the most common Loxen adverse events reported to the FDA?

Fall
42 (3.22%)
Drug Exposure During Pregnancy
41 (3.14%)
Thrombocytopenia
22 (1.69%)
Renal Failure
19 (1.46%)
Cytolytic Hepatitis
16 (1.23%)
Drug Interaction
16 (1.23%)
Malaise
16 (1.23%)
Caesarean Section
15 (1.15%)
Hypotension
15 (1.15%)
Renal Failure Acute
15 (1.15%)
Anaemia
14 (1.07%)
Show More Show More
Confusional State
14 (1.07%)
Cerebral Haematoma
13 (1%)
Oedema Peripheral
13 (1%)
Dyspnoea
12 (.92%)
Haemoglobin Decreased
12 (.92%)
Respiratory Distress
12 (.92%)
Acute Pulmonary Oedema
11 (.84%)
Agranulocytosis
11 (.84%)
Orthostatic Hypotension
11 (.84%)
Neutropenia
10 (.77%)
Cardio-respiratory Arrest
9 (.69%)
Cerebral Haemorrhage
9 (.69%)
Disorientation
9 (.69%)
Premature Baby
9 (.69%)
Pulmonary Oedema
9 (.69%)
Pyrexia
9 (.69%)
Alanine Aminotransferase Increased
8 (.61%)
Anuria
8 (.61%)
Blood Creatinine Increased
8 (.61%)
Bradycardia
8 (.61%)
Cholestasis
8 (.61%)
Coma
8 (.61%)
Hypertension
8 (.61%)
Intra-uterine Death
8 (.61%)
Rhabdomyolysis
8 (.61%)
Septic Shock
8 (.61%)
Somnolence
8 (.61%)
Transaminases Increased
8 (.61%)
Aspartate Aminotransferase Increase...
7 (.54%)
General Physical Health Deteriorati...
7 (.54%)
Hepatic Enzyme Increased
7 (.54%)
Hepatitis
7 (.54%)
Hypokalaemia
7 (.54%)
Toxic Epidermal Necrolysis
7 (.54%)
Vomiting
7 (.54%)
Acute Coronary Syndrome
6 (.46%)
Amnesia
6 (.46%)
Cardiac Murmur
6 (.46%)
Convulsion
6 (.46%)
Eczema
6 (.46%)
Electrocardiogram Repolarisation Ab...
6 (.46%)
Electroencephalogram Abnormal
6 (.46%)
Flushing
6 (.46%)
International Normalised Ratio Incr...
6 (.46%)
Leukopenia
6 (.46%)
Loss Of Consciousness
6 (.46%)
Sudden Death
6 (.46%)
Syncope
6 (.46%)
Arrhythmia
5 (.38%)
Atrial Fibrillation
5 (.38%)
Back Pain
5 (.38%)
Cough
5 (.38%)
Eosinophilia
5 (.38%)
Erythema Multiforme
5 (.38%)
Fatigue
5 (.38%)
Haematemesis
5 (.38%)
Haematoma
5 (.38%)
Jaundice
5 (.38%)
Maternal Drugs Affecting Foetus
5 (.38%)
Multi-organ Failure
5 (.38%)
Pleural Effusion
5 (.38%)
Pulmonary Embolism
5 (.38%)
Rash Maculo-papular
5 (.38%)
Rheumatoid Factor Increased
5 (.38%)
Splenomegaly
5 (.38%)
Toxic Skin Eruption
5 (.38%)
Acute Generalised Exanthematous Pus...
4 (.31%)
Blood Bilirubin Increased
4 (.31%)
Cardiogenic Shock
4 (.31%)
Cerebrovascular Accident
4 (.31%)
Chest Discomfort
4 (.31%)
Coagulopathy
4 (.31%)
Condition Aggravated
4 (.31%)
Conjunctivitis
4 (.31%)
Crepitations
4 (.31%)
Gastrointestinal Haemorrhage
4 (.31%)
Hyponatraemia
4 (.31%)
Lactic Acidosis
4 (.31%)
Lymphopenia
4 (.31%)
Neonatal Respiratory Distress Syndr...
4 (.31%)
Normochromic Normocytic Anaemia
4 (.31%)
Rales
4 (.31%)
Red Blood Cell Count Decreased
4 (.31%)
Spinal Compression Fracture
4 (.31%)
Tachyarrhythmia
4 (.31%)
Wrist Fracture
4 (.31%)
Bladder Distension
3 (.23%)
Blood Alkaline Phosphatase Increase...
3 (.23%)
Blood Thyroid Stimulating Hormone I...
3 (.23%)
Blood Urea Increased
3 (.23%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Loxen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Loxen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Loxen

What are the most common Loxen adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Loxen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Loxen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Loxen According to Those Reporting Adverse Events

Why are people taking Loxen, according to those reporting adverse events to the FDA?

Hypertension
191
Drug Use For Unknown Indication
140
Essential Hypertension
36
Product Used For Unknown Indication
20
Premature Labour
14
Tocolysis
9
Show More Show More
Pre-eclampsia
7
Ischaemic Cardiomyopathy
5
Pregnancy Induced Hypertension
4
Drug Exposure During Pregnancy
4
Myocardial Ischaemia
3
Cerebrovascular Accident
3
Hypertensive Cardiomyopathy
3
Secondary Hypertension
3
Threatened Labour
2
Complication Of Pregnancy
2
Malignant Hypertension
2
Blood Pressure Increased
2
Uterine Contractions During Pregnan...
1
Ischaemia
1
Delirium
1
Ill-defined Disorder
1
Blood Pressure Inadequately Control...
1
Hypertensive Heart Disease
1
Cardiovascular Disorder
1

Loxen Case Reports

What Loxen safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Loxen. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Loxen.